abbreviatioNs CN = cranial nerve; GTR = gross-total resection; ICD-O-3 = International Classification of Diseases for Oncology-Third Edition; MPNST = malignant peripheral nerve sheath tumors; NF, NF1, NF2 = neurofibromatosis, NF Type 1, NF Type 2; NOS = not otherwise specified; NTR = near-total resection; SEER = Surveillance, Epidemiology, and End Results; STR = subtotal resection; VS = vestibular schwannoma. To date the literature has focused on MPNSTs occurring after radiation therapy for presumed benign vestibular schwannomas (VSs), while MPNSTs arising without prior irradiation have received little attention. The objectives of the current study are to characterize the epidemiology, clinical presentation, disease course, and outcome using a large national cancer registry database and a systematic review of the English literature. Additionally, a previously unreported case is presented. methods The authors conducted an analysis of the Surveillance, Epidemiology, and End Results (SEER) database, a systematic review of the literature, and present a case report. Data from all patients identified in the SEER database with a diagnosis of MPNST involving the eighth CN, without a history of prior radiation, were analyzed. Additionally, all cases reported in the English literature between January 1980 and March 2015 were reviewed. Finally, 1 previously unreported case is presented. results The SEER registries identified 30 cases between 1992 and 2012. The average incidence was 0.017 per 1 million persons per year (range 0.000-0.0687 per year). The median age at diagnosis was 55 years, and 16 (53%) were women. Thirteen cases were diagnosed upon autopsy. Of the 17 cases diagnosed while alive, the median follow-up was 118 days, with 3 deaths (18%) observed. When compared with the incidence of benign VS, 1041 VSs present for every 1 MPNST arising from the eighth CN. Including a previously unreported case from the authors' center, a systematic review of the English literature yielded 24 reports. The median age at diagnosis was 44 years, 50% were women, and the median tumor size at diagnosis was 3 cm. Eleven patients (46%) reported isolated audiovestibular complaints typical for VS while 13 (54%) exhibited facial paresis or other signs of a more aggressive process. Treatment included microsurgery alone, microsurgery with adjuvant radiation, or microsurgery with chemoradiation. Sixty-one percent of patients receiving treatment experienced recurrence, 22% of which were diagnosed with drop metastases to the spine. Ultimately, 13 patients (54%) died of progressive disease at a median of 3 months following diagnosis. The ability to achieve gross-total resection was the only feature that was associated with improved disease-specific survival. coNclusioNs MPNSTs of the eighth CN are extremely rare and portend a poor prognosis. Nearly half of patients initially present with findings consistent with a benign VS, often making an early diagnosis challenging. In light of these data, early radiological and clinical follow-up should be considered in those who elect nonoperative treatment, particularly in patients with a short duration of symptoms or atypical presentation. These data also provide a baseline rate of malignancy that should be considered when estimating the risk of malignant transformation following stereotactic radiosurgery for VS.
M alignant peripheral nerve sheath tumors (MPNSTs) are a rare and heterogeneous group of neoplasms composing 5%-10% of all softtissue sarcomas with an incidence of approximately 1 per million people per year. 30, 42, 44 MPNSTs may arise de novo unrelated to a major nerve, within normal peripheral neural tissue, or from precursor lesions such as plexiform neurofibromas or less commonly, schwannomas. 42 The majority of MPNSTs arise in the deep tissues of the proximal upper and lower extremities commonly involving the sciatic nerve, brachial plexus, or sacral plexus, while less than 5% involve the cranial base. 2, 17, 42 Of the cranial nerve (CN) and intracranial MPNSTs, the seventh-eighth CN bundle is most commonly affected. 30, 44 Primary risk factors for MPNST development include neurofibromatosis Type 1 (NF1) and a prior history of radiation therapy. 30, 42, 44 The majority of the literature on eighth CN MPNSTs has focused on cases that developed following radiation therapy, while very little attention has been given to lesions arising without a prior history of ionizing radiation. 8, 40, 45, 46 Given the paucity of data describing the latter, the authors sought to characterize the epidemiology, disease presentation, and clinical course of eighth CN MPNSTs, using a large national cancer registry, as well as a systematic review of the English literature. Furthermore, we include 1 previously unreported case treated at the authors' center within the last year.
methods tumor registry analysis
The Surveillance, Epidemiology, and End Results (SEER) database includes a set of 20 population-based tumor registries covering approximately 28% of the US. Cases were selected by coding for International Classification of Diseases for Oncology-Third Edition (ICD-O-3) codes for 9540/3 (malignant peripheral nerve sheath tumor), 9560/3 (neurilemmoma, malignant), and 8561/3 (triton tumor, malignant) with associated topography code (C72.4) for auditory and vestibular nerve. Cases with a prior history of radiation were excluded, as were cases with a prior history of vestibular schwannoma (VS) that received radiation therapy. As SEER is a set of populationbased registries, incidence may be calculated. The annual population denominators for the registries were taken from SEER-Stat, and the incidence from 1992 to 2012 was plotted. Additionally, to draw a comparison of the incidence of eighth CN MPNST and benign VS, data were extracted using the ICD-0-3 code 9560/0 (benign schwannoma) with associated topography code C72.4 (auditory and vestibular nerve) from 2004 to 2012, the years SEER began cataloguing benign VS.
systematic review of the literature
The PubMed database (National Library of Medicine, http://www.ncbi.nlm.nih.gov) was searched from January 1, 1980, to March 1, 2015, using MPNST-and VS-relevant MeSH (Medical Subject Headings) and non-MeSH search terms. "Malignant" AND "nerve" combined with other more specific terms including "vestibular," "acoustic," "intracranial," "cranial," "cerebellopontine," AND "internal auditory canal" were queried. Potential references were then hand-searched based on the titles and abstracts to exclude laboratory-only studies and titles not relevant to the topic. Links to "related citations in PubMed" and the bibliography from highly relevant studies were explored to ensure all relevant studies were captured. Individual entries were cross-checked to eliminate duplicate publications reported by more than 1 journal. Reports describing MPNSTs involving other CNs or generically located in the cerebellopontine angle without data regarding nerve of origin were excluded. 7 There were 7 excluded cases that were labeled highly proliferative, atypical, or melanotic without an explicit diagnosis of malignancy. 4, 20, 26, 36, 51 A total of 43 malignant tumors of the eighth CN were identified. After excluding 16 cases of eighth CN MPNSTs that occurred following radiation, 1, 3, 10, 11, 19, 27, 29, 32, 33, 39, 41, 44, 47, 52, 54, 55 a total of 27 reports remained. Two were subsequently excluded based on non-English publication language. 43, 56 Finally, 1 case was published twice and was tallied only a single time in analysis. 28, 34 Thus, when including the current case report, 24 unique cases met inclusion criteria and were analyzed (Fig. 1) . 5, 9, [12] [13] [14] [15] [16] 18, [22] [23] [24] [25] 28, 31, 34, 35, 37, 44, 48, 50, 53 Data including patient demographics, presence of NF1 or NF2, presenting symptoms, tumor size, treatment strategy, histopathology, recurrence, survival, and duration of clinical follow-up were extracted and presented in tabular form. For cases that developed after resection of a benign VS, details regarding follow-up used the time of diagnosis of malignancy as the starting point. Maximum dimension was used for tumor size. Data were summarized with means, medians, and ranges, or frequency counts and percentages.
Because the SEER database samples 28% of the US population, and within the systematic review of the literature there were 10 reports published by US centers between 1992 and 2012, it can be estimated that approximately 2-3 cases from the systematic literature review were also included in the SEER analysis. However, this overlap should not skew study results because these 2 data sets were analyzed and presented separately.
results case report
A 25-year-old man presented to a local care facility after experiencing a 3-month history of progressive leftsided hearing loss and tinnitus, nonvertiginous imbalance, and worsening of baseline headaches. An audiogram demonstrated mild sensorineural hearing loss with only 40% speech discrimination on the left and normal hearing on the right, and MRI revealed a 1.4-cm left-sided internal auditory canal mass consistent with a VS (Fig. 2) . The patient denied a history of facial nerve symptomatology and reported no personal history of ionizing radiation or family history of NF1 or NF2.
The patient was subsequently referred to the authors' center for management. On examination the patient had normal facial nerve function and there were no stigmata of NF1 or NF2. After reviewing the options, the patient and family elected to pursue resection. The patient subsequently underwent an uncomplicated translabyrinthine approach with gross-total tumor resection. Postoperatively, the patient had normal facial nerve function, and surprisingly experienced no acute postoperative vertigo and was without nystagmus. Intraoperative frozen section pathology revealed a spindle cell neoplasm. However, permanent sections revealed a highly cellular tumor composed of spindle-shaped and epithelioid cells, showing moderate cytological anaplasia and brisk mitotic activity. On immunohistochemical staining, these cells diffusely and strongly expressed S100 protein, showed retained INI-1 expression, and were negative for the melanocytic markers HMB-45 and Melan-A. The combined histological and immunophenotypic features were considered consistent with an epithelioid MPNST (Fig. 3) .
Following final histopathological review, the patient underwent postoperative MRI of the head and whole-body PET CT for initial staging. MRI confirmed gross-total resection (GTR) and nuclear medicine imaging revealed no evidence for local, regional, or distant metastasis (Fig.  4) . It was recommended that the patient receive adjuvant intensity-modulated radiotherapy without chemotherapy; however, after reviewing his options the patient and family elected to forgo planned postoperative radiation and the patient is currently being followed closely with serial MRI. At the time of writing this paper, 3 months following surgery, the patient had no evidence of clinical or radiological recurrence.
analysis of National tumor registry data
The SEER database contained 30 cases between 1992 and 2012. The average incidence was 0.017 per 1 million persons per year (range 0.000-0.0687 per year). Utilizing the SEER database, it was determined that 1041 VSs present for every 1 case of an eighth CN MPNST. The median age at diagnosis was 55 years (mean 55.3 years, range 28-79 years), and 16 (53.3%) were women. Most patients reported non-Hispanic white ethnicity (n = 21, 70.0%), followed by Hispanic (n = 5, 16.7%), non-Hispanic black (n = 3, 10.0%) and other or unknown (n = 1, 3.3%). Thirteen patients (43.3%) were diagnosed upon autopsy and there- fore did not receive treatment, 12 (40.0%) received GTR, 3 (10.0%) subtotal resection (STR), and 2 (6.6%) surgery not otherwise specified (NOS) or status of surgery unknown. Of the 17 cases diagnosed while alive, the median followup was 118 days, with 3 deaths observed.
systematic review of the literature
Including the above-described case report, a total of 24 unique cases met inclusion criteria and were analyzed. 5, 9, [12] [13] [14] [15] [16] 18, [22] [23] [24] [25] 28, 31, 34, 35, 37, 44, 48, 50, 53 The median age of these 24 patients was 44 years (mean 43.3 years, range 1.5-77 years) and 12 (50%) were women. Two patients (8.3%) had NF2, while 1 (4.2%) had NF1. Thirteen patients (54.2%) presented with varying severities of facial paresis, hearing loss was universally present (20 of 20 cases) in cases where hearing status was documented, and dizziness, imbalance, or ataxia was reported in 13 cases (54.2%). The rate of audiological deterioration could not be analyzed secondary to incomplete reporting in the literature. In 11 reports (45.8%) the patient initially presented with symptoms typical for a benign VS, while the remaining exhibited clinical features suggesting a more aggressive process, including facial weakness; trigeminal neuropathy; lower CN dysfunction; diplopia from third, fourth, or sixth CN involvement; or global neurological decline (Table 1) . There were no published cases of spinal metastasis at primary presentation. Primary tumor size was available in 14 reports; the median tumor size prior to treatment was 3 cm (mean 3.2 cm, range 1.5-5.4 cm). Nine cases (37.5%) had features to suggest the possibility that the MPNST arose from a benign VS precursor. Specifically, 4 tumors demonstrated coexisting portions of benign schwannoma background; 4 patients had prior resection documenting VS; and 1 had undergone imaging 10 years earlier, which documented a small lesion consistent with a VS. Twenty-three (95.8%) of 24 cases underwent resection, 7 (29.2%) received adjuvant radiation therapy following resection via a variety of radiation delivery techniques, and 2 (8.3%) also received adjuvant chemotherapy. One patient died within 2 months of presentation without treatment. Fourteen (60.9%) of 23 patients receiving treatment experienced disease recurrence; 5 (35.7%) of these 14 had evidence of spinal metastasis. Ultimately 13 (54.2%) of 24 published cases reported death from progressive disease at a median of 3 months (mean 5.5 months, range 1-27 months) following initial diagnosis (Table 2 ). When analyzing age, sex, treatment modality, and symptomatology at presentation, the only feature that was found to be statistically significantly associated with improved diseasespecific survival was GTR versus incomplete resection (p = 0.004, 2-tailed Fisher's exact test; Fig. 5 ).
discussion
Intracranial and CN MPNSTs are rare, representing less than 5% of all reported cases of MPNSTs overall. 2, 17, 42 Prior studies have demonstrated that intracranial MPNSTs are divergent from MPNSTs elsewhere with respect to pathogenesis and risk factors. 30, 44 In the trunk and limbs approximately half of all MPNSTs are associated with NF1 and most frequently arise from a preexisting plexiform neurofibroma. In contrast, intracranial lesions are more likely to develop from normal neural tissue, precursor schwannoma, and in patients with NF2. Notably, of the 24 unique cases reported in the literature, 2 occurred in patients with NF2. Thus, NF2-associated eighth CN tumors appear to have a slightly higher rate of malignancy than sporadic tumors, a finding that parallels reports from the postradiation literature. 8 Given the increasing number of patients receiving primary stereotactic radiosurgery worldwide for benign intracranial lesions, much of the literature over the past 2 decades has focused on so-called radiation-induced or radiation-associated secondary malignancies, while eighth CN MPNSTs arising without prior irradiation have received much less attention. The authors recently treated a young man with microsurgical resection for a presumed benign VS, without prior history of radiation, only to discover an epithelioid MPNST on permanent section pathological analysis. Notably, this is the first occurrence of an eighth CN MPNST occurring in a patient without prior radiation therapy that the senior author has observed in more than 600 VS surgeries. Given the paucity of literature on this subject, we sought to review all prior published cases and to use the SEER database to further elucidate the epidemiology of this rare malignancy.
Including the recent case managed at our institution, we identified 24 unique accounts of eighth CN MPNSTs occurring without prior irradiation in the English literature. There was an equal distribution of sex, and the median age at diagnosis was 44 years, which is more than 10 years younger than the average age at presentation for benign sporadic VS. 49 Prior to data analysis, the authors posited that the great majority of patients with eighth CN MPNSTs would present with atypical symptoms such as facial paralysis or telling radiological features such as illdefined margins, brainstem edema, or internal necrosis; rather, these data demonstrate that approximately half of patients present with symptoms and findings consistent with typical VS. The SEER database estimated an average annual incidence of 0.017 per 1 million persons per year. When comparing this to the average estimated incidence of VSs that present to medical attention, we found that 1 in every 1041 eighth CN tumors is malignant. While rare, this information should be considered when determining radiological follow-up for patients who elect initial nonoperative therapy. Specifically, it would be reasonable to consider earlier MRI, such as 3 months following initial imaging, in patients with a short duration of symptoms or particularly for those with an atypical presentation such as facial paresis or lower CN dysfunction.
This review demonstrates that the overall prognosis of eighth CN MPNSTs is poor. Over half of published cases reported death from progressive disease at a median of 3 months, a finding that has been corroborated by other studies. 15, 30, 44 It is very likely that disease-specific mortality estimates would only increase if this cohort had been followed longer. In a 2010 review, Gousias reviewed 42 cases of intracranial MPNSTs and found that on univariate analysis, GTR, radiotherapy, and female sex were beneficial prognostic factors; however, GTR was the only independent predictor of prolonged overall survival. 15 Similarly, we found that the frequency of disease-specific mortality was lower in those treated with GTR compared with STR. Given the high-grade infiltrative nature of MPNSTs and the inability to achieve wide negative margins in the cerebellopontine angle and skull base without significant morbidity, resection combined with adjuvant radiation with or without chemotherapy is warranted in most cases. 15, 30, 44 Disease surveillance should include frequent MRI of the complete neuraxis to detect early local recurrence or spinal drop metastasis.
As an aside, this issue raises an interesting question regarding the true risk of secondary malignancy following stereotactic radiosurgery. Because we found that nearly half of the patients in our systematic review of the literature presented with features typical of VS, it very likely that at least several MPNSTs have been treated with pri- mary radiosurgery for presumed benign VSs. In 1 such published case, the authors suspected this scenario given the atypical behavior of the tumor immediately following radiosurgery. 29 In another publication, Comey et al. reported a case of an MPNST that was diagnosed 5 years following primary radiosurgery. 10 After experiencing rapid tumor growth the patient underwent microsurgery, and pathological analysis demonstrated a malignant tumor without any background features of benign schwannoma. In both cases, the authors surmised that the patient had received radiosurgery for what was, in fact, a malignant tumor all along. However, it would have been just as logical to conclude that both cases were radiation-induced without histological evidence at the time of initial treatment, particularly the latter case with a latency period of 5 years in accordance with Cahan et al.'s criteria. 6 Several studies have estimated the risk of malignant transformation following radiosurgery for VS to be between approximately 1 in 500 to 1 in 2000. 21, 38, 45 Interestingly, this is very similar to the rate of MPNSTs developing without prior irradiation in the current study. While there has been a rise in the number of published cases of eighth CN MPNSTs since 2000, only approximately half occur in patients without prior radiation treatment. 11, 38, 46 While clearly radiation induction is a real phenomenon, particularly in the NF2 population, these data would suggest that we are likely overestimating the risk of malignant transformation following low-dose stereotactic radiation for nonsyndromic VSs.
conclusions
Eighth CN MPNSTs arising without a history of prior radiation therapy are exceptionally rare. In contrast to MPNSTs found elsewhere that are commonly associated with NF1 and preexisting plexiform neurofibroma, MPNSTs of the eighth CN are more frequently associated with preexisting schwannoma, NF2, or de novo tumorigenesis. Epidemiological estimates derived from national tumor registry data demonstrate that approximately 1 MPNST involving the vestibulocochlear nerve will present for every 1041 VSs or an incidence of 0.017 per million population per year. Approximately half of the cases will initially present with symptoms and radiological features congruent with benign schwannoma. In light of these data, early radiological and clinical follow-up should be considered after initial evaluation in those who elect nonoperative treatment, particularly in patients with a short duration of symptoms or atypical presentation. These results also provide a baseline rate of malignancy that should be considered when estimating the risk of malignant transformation following stereotactic radiosurgery for VS.
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